Amgen (AMGN) Financials
Amgen (AMGN) Historical Financial Statements and Key Metrics for 1986 - 2023
Full Amgen financials for 1986 - 2023 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Amgen Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2023-Dec-31 | 8,196 | 5,084 (62.0 %) | 1,271 (15.5 %) | 767 (9.4 %) | 3,053 | 1.42 |
| 2023-Sep-30 | 6,903 | 5,097 (73.8 %) | 2,021 (29.3 %) | 1,730 (25.1 %) | 2,706 | 3.22 |
| 2023-Jun-30 | 6,986 | 5,173 (74.0 %) | 2,684 (38.4 %) | 1,379 (19.7 %) | 2,366 | 2.57 |
| 2023-Mar-31 | 6,105 | 4,385 (71.8 %) | 3,085 (50.5 %) | 2,841 (46.5 %) | 3,985 | 5.28 |
| 2022-Dec-31 | 6,839 | 5,092 (74.5 %) | 2,230 (32.6 %) | 1,616 (23.6 %) | 3,074 | 3.00 |
| 2022-Sep-30 | 6,652 | 5,064 (76.1 %) | 2,660 (40.0 %) | 2,143 (32.2 %) | 3,597 | 3.98 |
| 2022-Jun-30 | 6,594 | 5,084 (77.1 %) | 2,176 (33.0 %) | 1,317 (20.0 %) | 2,687 | 2.45 |
Full historical income statements for 1986 - 2023 is included in the
US Historical Financials dataset.
Amgen Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2023-Dec-31 | 97,154 | 90,922 | 64,613 | 6,232 | 10,944 |
| 2023-Sep-30 | 90,534 | 82,878 | 60,468 | 7,656 | 34,741 |
| 2023-Jun-30 | 90,269 | 83,488 | 61,544 | 6,781 | 34,248 |
| 2023-Mar-31 | 88,720 | 83,372 | 61,595 | 5,348 | 31,561 |
| 2022-Dec-31 | 65,121 | 61,460 | 38,945 | 3,661 | 9,305 |
| 2022-Sep-30 | 63,700 | 60,047 | 38,704 | 3,653 | 11,478 |
| 2022-Jun-30 | 59,294 | 56,875 | 36,522 | 2,419 | 7,183 |
Full historical balance sheet data for 1986 - 2023 is included in the
US Historical Financials dataset.
Amgen Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2023-Dec-31 | 538 | -27,089 | 2,754 | 289 |
| 2023-Sep-30 | 2,760 | -262 | -2,005 | 2,760 |
| 2023-Jun-30 | 4,109 | -211 | -1,210 | 3,838 |
| 2023-Mar-31 | 1,064 | 1,358 | 21,509 | 720 |
| 2022-Dec-31 | 2,649 | -3,473 | -1,049 | 2,309 |
| 2022-Sep-30 | 2,978 | -267 | 1,588 | 2,818 |
| 2022-Jun-30 | 1,930 | -2,193 | -1,062 | 1,684 |
Full historical cash flow data for 1986 - 2023 is included in the
US Historical Financials dataset.
Amgen Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2023-Dec-31 | 154,091 | 207,760 | 18.80 | 50.23 | 24.73 |
| 2023-Sep-30 | 143,787 | 169,514 | 20.83 | 20.78 | 18.78 |
| 2023-Jun-30 | 118,781 | 146,077 | 17.00 | 21.53 | 17.52 |
| 2023-Mar-31 | 129,094 | 159,130 | 21.15 | 11.36 | 24.14 |
| 2022-Dec-31 | 140,512 | 171,828 | 20.55 | 21.74 | 38.38 |
| 2022-Sep-30 | 120,589 | 149,791 | 18.13 | 14.07 | 33.01 |
| 2022-Jun-30 | 130,166 | 161,485 | 19.74 | 24.71 | 53.81 |
Full historical valuation and operating metrics for 1986 - 2023 are included in the
US Historical Financials dataset.